Showing 1,511 results

Filters Content type: News, Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Finance & funding

Rapid adoption of generic HIV drugs could save NHS £7 billion by 2033

News
10 May 2019
Pharmaceutical industry

Group Of Developed Countries Seek To Delay Italian Proposal On Drug Price Transparency

Editor's pick
Health Policy Watch
7 May 2019
Pharmaceutical industry

Gilead Sciences Returns to Growth in the First Quarter

Editor's pick
Motley Fool
3 May 2019
HIV treatment for children & young people

Why has the uptake of lopinavir/ritonavir oral pellets for children been slow?

News
2 May 2019
PrEP policies & guidelines

Gilead: Stop Blocking PrEP

Editor's pick
Act Up Dublin
1 May 2019
Elimination of hepatitis C

NHS trumpets Hep C deal, quietly drops 2025 elimination target after legal row

Editor's pick
pharmaphorum
30 April 2019
Elimination of hepatitis C

NHS England strikes world leading deal to help eliminate hepatitis C

Editor's pick
NHS England
30 April 2019
Injectable & long-acting HIV treatment

ViiV Healthcare submits New Drug Application to US FDA for the first monthly, injectable, two-drug regimen of cabotegravir and rilpivirine

Editor's pick
ViiV press release
29 April 2019
New & experimental HIV treatments

ViiV Healthcare announces CHMP Positive Opinion for Dovato® (dolutegravir/lamivudine) as a once-daily, single-pill, two-drug regimen for the treatment of HIV infection

Editor's pick
ViiV press release
26 April 2019
Activism & civil society

How Activists Uncovered CDC's Ownership of Truvada PrEP Patents

Editor's pick
The Body
25 April 2019
Harm reduction

New “Generic” Naloxone: Expect More Big-Pharma Sleight of Hand

Editor's pick
Filter
25 April 2019
Pharmaceutical industry

US: The Justice Department Is Looking Into Gilead’s PrEP Profits

Editor's pick
Out
25 April 2019
Pharmaceutical industry

HIV drugmakers ViiV, Gilead top 2018 pharma reputation survey

Editor's pick
FiercePharma
23 April 2019
Pharmaceutical industry

Gilead's first big TV push for triple combo Biktarvy showcases HIV diversity

Editor's pick
FiercePharma
18 April 2019
PrEP science

Letter to FDA Regarding Application for Descovy as Pre-Exposure Prophylaxis for HIV

Editor's pick
Treatment Action Group
17 April 2019
Access to healthcare

“Dialogue” Highlighted As Way Forward At Closure Of WHO Fair Pricing Forum

Editor's pick
Health Policy Watch
15 April 2019
Pharmaceutical industry

Will new TB treatments reach those who need them most?

Editor's pick
Devex
15 April 2019
Access to healthcare

Tackling the high price of medicine

Editor's pick
Daily Maverick
15 April 2019
Pharmaceutical industry

Dovato Is a Newly Approved Two-Drug HIV Regimen. Do Fewer Drugs Mean a Lower-Cost HIV Treatment?

Editor's pick
The Body
15 April 2019
Side effects

Gilead Lawsuits: 41 HIV and PrEP Patients File California Personal Injury Case Over Gilead's TDF-Based Drugs

Editor's pick
Associated Press
12 April 2019
Starting treatment

US regulators approve new two-drug combination pill for HIV

News
11 April 2019
Treatment simplification strategies

FDA approves first two-drug complete regimen for HIV-infected patients who have never received antiretroviral treatment

Editor's pick
Food & Drug Administration
9 April 2019
PrEP policies & guidelines

The CDC Director got shouted down by angry AIDS activists during a completely tone deaf speech

Editor's pick
LGBTQ Nation
5 April 2019
Pharmaceutical industry

Kenya steps up Aids battle as building starts on $100m drug factory

Editor's pick
The Guardian
29 March 2019